
Isoray ISR
Quarterly report 2026-Q1
added 05-11-2026
Isoray EV - Enterprise Value 2011-2026 | ISR
Annual EV - Enterprise Value Isoray
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.3 M | 13.3 M | 23.6 M | 25.1 M | -3.41 M | 116 M | 21.9 M | 36.2 M | 29.3 M | 33.9 M | 72.7 M | 104 M | 19.8 M | 30.2 M | 25.2 M | -1.68 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 116 M | -3.41 M | 35.9 M |
EV - Enterprise Value of other stocks in the Medical instruments industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
636 M | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
20.4 B | $ 67.94 | 0.09 % | $ 13.5 B | ||
|
Luminex Corporation
LMNX
|
456 M | - | - | $ 1.75 B | ||
|
Glaukos Corporation
GKOS
|
7.02 B | $ 128.99 | 1.72 % | $ 7.38 B | ||
|
Akers Biosciences, Inc.
AKER
|
631 M | - | -9.52 % | $ 20.6 M | ||
|
Alcon
ALC
|
7.99 B | $ 66.99 | 0.21 % | $ 40.4 B | ||
|
ICU Medical
ICUI
|
3.36 B | $ 144.06 | 1.31 % | $ 3.55 B | ||
|
Intuitive Surgical
ISRG
|
170 B | $ 414.66 | 0.87 % | $ 148 B | ||
|
iRhythm Technologies
IRTC
|
5.71 B | $ 113.31 | -0.3 % | $ 3.63 B | ||
|
Antares Pharma, Inc.
ATRS
|
758 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
726 M | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
66.3 M | - | - | $ 282 M | ||
|
Repro Med Systems
KRMD
|
201 M | $ 3.98 | -0.46 % | $ 184 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
6.3 B | - | -0.05 % | $ 10.3 B | ||
|
LeMaitre Vascular
LMAT
|
2.73 B | $ 91.92 | -0.05 % | $ 2.08 B | ||
|
Ekso Bionics Holdings
EKSO
|
36 M | - | - | $ 28.6 M | ||
|
Masimo Corporation
MASI
|
10.4 B | $ 179.95 | - | $ 9.59 B | ||
|
Microbot Medical
MBOT
|
120 M | $ 1.84 | 3.09 % | $ 84.3 M | ||
|
Varian Medical Systems, Inc.
VAR
|
451 M | - | -0.02 % | $ 16.3 B | ||
|
Milestone Scientific
MLSS
|
27.7 M | $ 0.36 | 1.44 % | $ 29.5 M | ||
|
Merit Medical Systems
MMSI
|
5.51 B | $ 66.54 | 0.02 % | $ 3.94 B | ||
|
electroCore
ECOR
|
13.4 M | $ 10.12 | -1.27 % | $ 85.8 K | ||
|
Envista Holdings Corporation
NVST
|
3.62 B | $ 25.05 | 1.83 % | $ 4.21 B | ||
|
Haemonetics Corporation
HAE
|
2.56 B | $ 78.11 | -0.12 % | $ 3.69 B | ||
|
STERIS plc
STE
|
24 B | $ 207.07 | -0.24 % | $ 20.3 B | ||
|
STAAR Surgical Company
STAA
|
895 M | $ 28.72 | 1.22 % | $ 1.42 B | ||
|
InfuSystem Holdings
INFU
|
157 M | $ 8.92 | -2.41 % | $ 184 M | ||
|
Teleflex Incorporated
TFX
|
8.89 B | $ 129.55 | -0.71 % | $ 5.78 B | ||
|
Utah Medical Products
UTMD
|
117 M | $ 67.91 | 0.1 % | $ 220 M | ||
|
West Pharmaceutical Services
WST
|
17.9 B | $ 328.99 | 0.05 % | $ 23.8 B | ||
|
Pulse Biosciences
PLSE
|
1.64 B | $ 25.32 | 3.9 % | $ 1.71 B | ||
|
DENTSPLY SIRONA
XRAY
|
6.29 B | $ 10.24 | 1.24 % | $ 2.04 B | ||
|
Retractable Technologies
RVP
|
85.7 M | $ 0.69 | -1.11 % | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
175 M | $ 61.5 | -1.13 % | $ 202 M | ||
|
Predictive Oncology
POAI
|
-5.62 M | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
989 M | $ 27.17 | 4.1 % | $ 1.3 B | ||
|
Stereotaxis
STXS
|
191 M | $ 1.87 | 1.63 % | $ 170 M | ||
|
Baxter International
BAX
|
21.6 B | $ 20.96 | 0.48 % | $ 10.8 B | ||
|
ResMed
RMD
|
36.5 B | $ 195.21 | 0.22 % | $ 28.5 B | ||
|
AtriCure
ATRC
|
1.55 B | $ 29.04 | 0.85 % | $ 1.39 B | ||
|
Harvard Bioscience
HBIO
|
78.6 M | $ 6.05 | -0.49 % | $ 269 M | ||
|
NeuroMetrix
NURO
|
8.29 M | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
396 M | $ 12.01 | -0.74 % | $ 491 M | ||
|
Becton, Dickinson and Company
BDX
|
55.5 B | $ 146.02 | -0.15 % | $ 42 B | ||
|
Nephros
NEPH
|
31.3 M | $ 3.29 | -1.58 % | $ 34.9 M | ||
|
OraSure Technologies
OSUR
|
98.2 M | $ 4.17 | -0.24 % | $ 306 M | ||
|
Repligen Corporation
RGEN
|
284 M | $ 132.6 | 1.54 % | $ 7.46 M |